SFA's Medical Advisory Board

Article Type

Changed

Wed, 05/13/2020 - 11:37

The board is headed by leading US sarcoma experts

The Medical Advisory Board of the Sarcoma Foundation of America includes the following leading oncologist authorities on sarcomas. More information are their treatment centers can be found at https://www.curesarcoma.org/patient-resources/sarcoma-treatment-centers/

Co-Chair: George Demetri, MD, Dana-Farber Cancer Institute
Co-Chair: Raphael Pollock, MD, PhD, The Ohio State University
Mark Agulnik, MD, FRCPC, Robert H. Lurie Comprehensive Cancer Center
Charles Forscher, MD, Cedars-Sinai Medical Center
John M. Goldberg, MD, H3 Biomedicine
Richard Gorlick, MD, MD Anderson Cancer Center
Lee Helman, MD, University of Southern California/Children’s Hospital Los Angeles
Eugenie S. Kleinerman, MD, MD Anderson Cancer Center
Andrew S. Kraft, MD, University of Arizona Cancer Center
Marc Ladanyi, MD, Memorial Sloan-Kettering Cancer Center
David M. Loeb, MD, PhD, Children’s Hospital at Montefiore
Crystal Mackall, MD, Stanford Cancer Institute
Robert Maki, MD, PhD, Cold Spring Harbor Laboratory
Paul A. Meyers, MD, Memorial Sloan-Kettering Cancer Center
Alberto Pappo, MD, St. Jude Children’s Research Hospital
Shreyaskumar Patel, MD, MD Anderson Cancer Center
Peter Pisters, MD, University Health Network
R. Lor Randall, MD, FACS, Huntsman Cancer Center, University of Utah
Richard F. Riedel, MD, Duke University Medical Center
Scott Schuetze, MD, University of Michigan
Samuel Singer, MD, Memorial Sloan-Kettering Cancer Center
Poul HB Sorensen, MD, PhD, University of British Columbia
William D. Tap, MD, Memorial Sloan-Kettering Cancer Center
Jonathan Trent, MD, PhD, Sylvester Comprehensive Cancer Center
Matt van de Rijn, MD, Stanford School of Medicine

Publications

The Sarcoma Journal

MDedge Hematology and Oncology

Topics

Sarcoma & GIST

Sections

From the Sarcoma Foundation of America

The board is headed by leading US sarcoma experts

The Medical Advisory Board of the Sarcoma Foundation of America includes the following leading oncologist authorities on sarcomas. More information are their treatment centers can be found at https://www.curesarcoma.org/patient-resources/sarcoma-treatment-centers/

Co-Chair: George Demetri, MD, Dana-Farber Cancer Institute
Co-Chair: Raphael Pollock, MD, PhD, The Ohio State University
Mark Agulnik, MD, FRCPC, Robert H. Lurie Comprehensive Cancer Center
Charles Forscher, MD, Cedars-Sinai Medical Center
John M. Goldberg, MD, H3 Biomedicine
Richard Gorlick, MD, MD Anderson Cancer Center
Lee Helman, MD, University of Southern California/Children’s Hospital Los Angeles
Eugenie S. Kleinerman, MD, MD Anderson Cancer Center
Andrew S. Kraft, MD, University of Arizona Cancer Center
Marc Ladanyi, MD, Memorial Sloan-Kettering Cancer Center
David M. Loeb, MD, PhD, Children’s Hospital at Montefiore
Crystal Mackall, MD, Stanford Cancer Institute
Robert Maki, MD, PhD, Cold Spring Harbor Laboratory
Paul A. Meyers, MD, Memorial Sloan-Kettering Cancer Center
Alberto Pappo, MD, St. Jude Children’s Research Hospital
Shreyaskumar Patel, MD, MD Anderson Cancer Center
Peter Pisters, MD, University Health Network
R. Lor Randall, MD, FACS, Huntsman Cancer Center, University of Utah
Richard F. Riedel, MD, Duke University Medical Center
Scott Schuetze, MD, University of Michigan
Samuel Singer, MD, Memorial Sloan-Kettering Cancer Center
Poul HB Sorensen, MD, PhD, University of British Columbia
William D. Tap, MD, Memorial Sloan-Kettering Cancer Center
Jonathan Trent, MD, PhD, Sylvester Comprehensive Cancer Center
Matt van de Rijn, MD, Stanford School of Medicine

The Medical Advisory Board of the Sarcoma Foundation of America includes the following leading oncologist authorities on sarcomas. More information are their treatment centers can be found at https://www.curesarcoma.org/patient-resources/sarcoma-treatment-centers/

Co-Chair: George Demetri, MD, Dana-Farber Cancer Institute
Co-Chair: Raphael Pollock, MD, PhD, The Ohio State University
Mark Agulnik, MD, FRCPC, Robert H. Lurie Comprehensive Cancer Center
Charles Forscher, MD, Cedars-Sinai Medical Center
John M. Goldberg, MD, H3 Biomedicine
Richard Gorlick, MD, MD Anderson Cancer Center
Lee Helman, MD, University of Southern California/Children’s Hospital Los Angeles
Eugenie S. Kleinerman, MD, MD Anderson Cancer Center
Andrew S. Kraft, MD, University of Arizona Cancer Center
Marc Ladanyi, MD, Memorial Sloan-Kettering Cancer Center
David M. Loeb, MD, PhD, Children’s Hospital at Montefiore
Crystal Mackall, MD, Stanford Cancer Institute
Robert Maki, MD, PhD, Cold Spring Harbor Laboratory
Paul A. Meyers, MD, Memorial Sloan-Kettering Cancer Center
Alberto Pappo, MD, St. Jude Children’s Research Hospital
Shreyaskumar Patel, MD, MD Anderson Cancer Center
Peter Pisters, MD, University Health Network
R. Lor Randall, MD, FACS, Huntsman Cancer Center, University of Utah
Richard F. Riedel, MD, Duke University Medical Center
Scott Schuetze, MD, University of Michigan
Samuel Singer, MD, Memorial Sloan-Kettering Cancer Center
Poul HB Sorensen, MD, PhD, University of British Columbia
William D. Tap, MD, Memorial Sloan-Kettering Cancer Center
Jonathan Trent, MD, PhD, Sylvester Comprehensive Cancer Center
Matt van de Rijn, MD, Stanford School of Medicine